FDA Inspection
David P. Walling, Ph.D.David P. Walling, Ph.D. – FDA Inspection, Jan 13, 2023
Record Details
This FDA Inspection record concerns David P. Walling, Ph.D., with an inspection on January 13, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 57c57951-6596-4170-b00f-3c4d9f4e7df5
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1195349
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
Other FDA inspections of David P. Walling, Ph.D.
7| Date | Classification | Office | Project area |
|---|---|---|---|
| May 14, 2021 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| March 19, 2018 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| March 11, 2015 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| January 23, 2015 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| May 9, 2014 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for David P. Walling, Ph.D.
- FDA Inspection 1143823 - 2021-05-14
- FDA Inspection 1063079 - 2018-03-19
- FDA Inspection 917428 - 2015-03-11
- FDA Inspection 911140 - 2015-01-23
- FDA Inspection 879347 - 2014-05-09
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.